Contact Us   |   Print Page   |   Sign In   |   Join
News and Press: Industry News

January Deadlines for NCATS SBIR/STTR Funding

Thursday, November 10, 2016   (0 Comments)
Posted by: Kate Oesterle
Share |

NCATS Small Business Innovation Research (SBIR) and Small Business Technology Transfer (STTR) Funding Applications Deadline:
Jan. 5, 2017


The National Center for Advancing Translational Sciences (NCATS) has several open SBIR and STTR program funding opportunities designed to help advance and commercialize translational research technologies. NCATS encourages applications particularly in these research areas: drug discovery and development, diagnostics and devices, bioinformatics and information technology, and clinical research management.

Benefits of Applying: SBIR and STTR funding is stable, predictable, not a loan and non-dilutive. Small businesses retain intellectual property rights, and awardees also are eligible to access other NIH-supported programs designed to help small businesses commercialize their technologies. 

All opportunities have an application deadline of Jan. 5, 2017, 5:00 p.m. local time.  

2016 Omnibus Solicitation
Small businesses, research and technology organizations are eligible to apply for the 2016 Omnibus Solicitation. Applications may address any stage of translation, from pre-clinical development through clinical evaluation, to intervention, implementation and dissemination. 

Other Funding Opportunities
SBIR Direct Phase II
Small businesses that have accomplished the objectives of a Phase I SBIR grant through non-SBIR funds can apply for SBIR direct to Phase II funding. Applicants must demonstrate scientific and technical merit, and feasibility of the prototype stage of developing a biomedical technology that has commercial potential. 

  • PAR-15-288: Direct Phase II SBIR Grants to Support Extended Development, Hardening, and Dissemination of Technologies in Biomedical Computing, Informatics, and Big Data Science
  • PAR-14-088: Direct Phase II SBIR Grants to Support Biomedical Technology Development

SBIR Technology Transfer
This funding opportunity encourages SBIR grant applications from small business concerns for projects to transfer technology out of the NIH intramural research labs into the private sector. 

Platform Delivery Technologies for Nucleic Acid Therapeutics
This funding opportunity is designed to incentivize small businesses to generate new technologies and products for delivering nucleic acids into cells and tissues for the purpose of treatment or prevention of human disease. 

 Learn more about current funding opportunities for small business at NCATS Small Business, including eligibility requirements and research priorities. Contact NCATS SBIR and STTR today to discuss your project idea. 

Connect with us! Like NCATS on Facebook and follow the Center on Twitter. Use #NCATSsbir to join the conversation.

***

NCATS' SBIR and STTR programs are engines of innovation for developing and commercializing tools, technologies and intervention platforms to support the creation of new therapeutics and diagnostics. SBIR and STTR are government set-aside programs for domestic small businesses to engage in research and development that has the potential for commercialization and public benefit.


Creating Value
by delivering business-critical resources & bottom line savings
Building Networks
by connecting Michigan's bio-industry one member at a time
Growing Talent
by creating opportunities that develop people & build organizations
Membership Software Powered by YourMembership  ::  Legal